Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X X Kong

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|May 20, 2026
[Translational therapeutic strategies and timing of surgery for peritoneal metastasis in colorectal cancer]L Liu, Y T Hu, X X Kong, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|November 17, 2017
[Antimicrobial resistance and molecular subtypes of <i>Salmonella typhi</i> and <i>Salmonella paratyphoid</i> isolates from Jiangsu province, 2012-2015]X X Kong, C Dong, H Ji, et al.
Journal of Endocrinological Investigation|July 9, 2011
Resveratrol, an effective regulator of ovarian development and oocyte apoptosisX-X Kong, Y-C Fu, J-J Xu, et al.
Epidemiology and Infection|May 25, 2017
First report of the qnrA determinant in Shigella sonnei isolated from ChinaH M Qian, T T Qin, G Y Liu, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|November 15, 2021
[Application of remote "Internet+" interactive mode in the management of patients with hypertension during normalized epidemic prevention and control of COVID-19]G H Sun, M Z Shen, W H Xu, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|March 1, 2026
[Restricted mean duration of response: a novel endpoint for efficacy evaluation in oncology clinical trials]X X Kong, R Y Huang, Y F Wang, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|September 18, 2024
[Application of IgG antibody combination of wild strain and epidemic strain of COVID-19 in identifying epidemic Omicron BA.5 strain infection]J J Chu, H Tian, C C Li, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|December 20, 2022
[Kinetics of SARS-CoV-2-specific antibodies among inactivated COVID-19 vaccine recipients, SARS-CoV-2 natural infection cases, and breakthrough cases]L R Jin, C C Li, C Chen, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|May 20, 2026
[Translational therapeutic strategies and timing of surgery for peritoneal metastasis in colorectal cancer]L Liu, Y T Hu, X X Kong, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|November 17, 2017
[Antimicrobial resistance and molecular subtypes of <i>Salmonella typhi</i> and <i>Salmonella paratyphoid</i> isolates from Jiangsu province, 2012-2015]X X Kong, C Dong, H Ji, et al.
Journal of Endocrinological Investigation|July 9, 2011
Resveratrol, an effective regulator of ovarian development and oocyte apoptosisX-X Kong, Y-C Fu, J-J Xu, et al.
Epidemiology and Infection|May 25, 2017
First report of the qnrA determinant in Shigella sonnei isolated from ChinaH M Qian, T T Qin, G Y Liu, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|November 15, 2021
[Application of remote "Internet+" interactive mode in the management of patients with hypertension during normalized epidemic prevention and control of COVID-19]G H Sun, M Z Shen, W H Xu, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|March 1, 2026
[Restricted mean duration of response: a novel endpoint for efficacy evaluation in oncology clinical trials]X X Kong, R Y Huang, Y F Wang, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|September 18, 2024
[Application of IgG antibody combination of wild strain and epidemic strain of COVID-19 in identifying epidemic Omicron BA.5 strain infection]J J Chu, H Tian, C C Li, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|December 20, 2022
[Kinetics of SARS-CoV-2-specific antibodies among inactivated COVID-19 vaccine recipients, SARS-CoV-2 natural infection cases, and breakthrough cases]L R Jin, C C Li, C Chen, et al.
Pageof 1